Quick Dispatch:
Your tirzepatide shortage over FDA Announces End of Tirzepatide Shortage: What This Means for Medspas and Compounders orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide shortage over FDA Announces End of Tirzepatide Shortage: What This Means for Medspas and Compounders ships.
Need Help?
Questions about tirzepatide shortage over FDA Announces End of Tirzepatide Shortage: What This Means for Medspas and Compounders, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide shortage over FDA Announces End of Tirzepatide Shortage: What This Means for Medspas and Compounders in your area.
FDA confirms tirzepatide shortage is still over, gives compounders a grace period
25.29
US judge sides with FDA's removal of Lilly's weight loss drug from shortage list
22.26
Lilly's weight-loss drug removed from FDA's shortage list
27.89
Eli Lilly's Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
24.96
FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease production of compounded versions of tirzepatide within the
22.26
The FDA says the Zepbound shortage is over. That's rattling the weight loss industry
23.11
The Outsourcing Facilities Association (OFA) is suing the FDA after the agency removed tirzepatide (Zepbound, Mounjaro) from the federal drug shortage list without proper notice. The lawsuit claims that the FDA failed
28.52
